Recursion Pharmaceuticals beat estimated earnings by 30.0%, reporting an EPS of $-0.21 versus an estimate of $-0.3. Revenue was up $30.99 million from the same period last year. During the previous ...

Shale drillers have turned the biggest oil field in the U.S. into a pressure cooker that is literally bursting at the seams. Producers in the Permian Basin of West Texas and New Mexico extract roughly ...

Upcoming SBS drama “No Tail To Tell” has unveiled the first stills of Lomon in character! “No Tail To Tell” is a fantasy romance that follows Eun Ho (Kim Hye Yoon), a quirky Gen Z gumiho (nine-tailed ...

A skydiving trip in Australia took a harrowing turn when one person’s parachute became entangled in the tail of the plane, stranding them at 15,000 feet. The aircraft, a Cessna 208 Caravan, was ...

Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that position, though. Recursion may not be a meme stock, but that doesn't make it a ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Interstellar comet 3I/ATLAS photographed by the Virtual Telescope Project at 11:31 p.m. EDT on ...

CNBC’s Jim Cramer answers calls from viewers and offers advice for their stock picks. More than 200 shots fired in deadly Kansas City, Kansas ambush; new details As national debt accelerates to $38 ...

Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals, recently sold a significant chunk of his company's common stock. The CEO of Recursion Pharmaceuticals recently disposed of 120 ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Customer journeys now move from messy questions to instant AI answers, making authentic problem-solving the real driver of conversions. The How AI Search Can Drive Sales & Boost Conversions webinar, ...